Breaking News Headlines Today | Ground News

See every side of every news story

thesentinel.com image

News from thesentinel.com

thesentinel.com’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Is thesentinel.com credible or reliable? Our Factuality score answers both of those questions. When it comes to thesentinel.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about thesentinel.com

Where is thesentinel.com located?thesentinel.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top thesentinel.com News

Energy Companies from Around the World Win Honors at S&P Global Energy's 27th Annual Platts Global Energy Awards

Australia · Australia

Energy Companies from Around the World Win Honors at S&P Global Energy's 27th Annual Platts Global Energy Awards

70% Center coverage: 33 sources

CNBC's Brian Sullivan Emceed as Winners from Australia, Brazil, China, Denmark, India, Singapore, Spain, UAE, UK, and US Were Announced See the Story

Yum China Expands Share Repurchase Authorization by US$1 Billion

Shanghai, China · Shanghai

Yum China Expands Share Repurchase Authorization by US$1 Billion

72% Center coverage: 32 sources

SHANGHAI, Dec. 11, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced today that its Board of Directors (the "Board") has increased the Company's share repurchase authorization by US$1 billion to…See the Story

Proton Therapy Shows Survival Benefit in Phase III Trial for Patients with Head and Neck Cancers

Cancer · United States

Proton Therapy Shows Survival Benefit in Phase III Trial for Patients with Head and Neck Cancers

76% Center coverage: 25 sources

A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT).See the Story

Breaking News Topics Related to thesentinel.com